In conclusion, these findings may provide novel insight into the cancer-promoting effects of USP18 and its potential clinical application in pancreatic cancer, which suggests that the USP18/Notch1/c-Myc pathway may act as a crucial regulator of pancreatic cancer progression. The gene discussed is USP18; the disease is pancreatic neoplasm.